A Case of Fulminant Type 1 Diabetes during Pregnancy

Tae-Seon Oh; Heesoo Jung; Hye Rim Kang; Tae Kyun Kim; Min Jeong Kwon; Soon Hee Lee; Jeong Hyun Park

doi:10.4093/jkd.2016.17.2.134

Journal List > J Korean Diabetes > v.17(2) > 1055012

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Oh, Jung, Kang, Kim, Kwon, Lee, and Park: A Case of Fulminant Type 1 Diabetes during Pregnancy

Case Report

J Korean Diabetes 2016;17(2):134-138.

Published online: 10 January 2016

DOI: https://doi.org/10.4093/jkd.2016.17.2.134

A Case of Fulminant Type 1 Diabetes during Pregnancy

Tae-Seon Oh, Heesoo Jung, Hye Rim Kang, Tae Kyun Kim, Min Jeong Kwon, Soon Hee Lee, Jeong Hyun Park

Department of Internal Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea

Corresponding author: Min Jeong Kwon Department of Internal Medicine, Inje University Busan Paik Hospital, 75 Bokji-ro, Busanjin-gu, Busan 47392, Korea, E-mail: koma911@naver.com

Received 7 August 2015 Revised 3 September 2015 Accepted 7 September 2015

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Fulminant type 1 diabetes is characterized by acute onset, no evidence of islet-related autoantibodies, low glycated hemoglobin(HbA1c) level at onset, and metabolic complications such as diabetic ketoacidosis. Fulminant type 1 diabetes development during pregnancy can result in severe maternal and fetal complications. Most of the patients with fulminant type 1 diabetes during pregnancy have been reported in Japan. In Korea, reports of fulminant type 1 diabetes during pregnancy are uncommon. We report a 36-year-old Korean woman with fulminant type 1 diabetes developed at 32 weeks of gestation who demonstrate a good outcome.

Keywords: Fulminant, Pregnancy, Type 1 diabetes

References

1. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003; 26(Suppl 1):S5–20.

2. Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y. A proposal of three distinct subtypes of type 1 diabetes mellitus based on clinical and pathological evidence. Ann Med. 2000; 32:539–43.

3. Tanaka S, Endo T, Aida K, Shimura H, Yokomori N, Kaneshige M, Furuya F, Amemiya S, Mochizuki M, Nakanishi K, Kobayashi T. Distinct diagnostic criteria of fulminant type 1 diabetes based on serum C-peptide response and HbA1c levels at onset. Diabetes Care. 2004; 27:1936–41.

4. Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y. Osaka IDDM Study Group. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. N Engl J Med. 2000; 342:301–7.

5. Imagawa A, Hanafusa T, Uchigata Y, Kanatsuka A, Kawasaki E, Kobayashi T, Shimada A, Shimizu I, Toyoda T, Maruyama T, Makino H. Fulminant type 1 diabetes: a nationwide survey in Japan. Diabetes Care. 2003; 26:2345–52.

6. Lee JH, Koh GP, Yang JK, Kim KH, Im DM, Park KY. A typical case of fulminant type 1 diabetes mellitus. J Korean Diabetes Assoc. 2007; 31:175–9.

7. Rhee SY, Chon S, Koh G, Oh S, Woo JT, Kim JW, Kim YS. A case of fulminant type 1 diabetes mellitus. Korean J Med. 2006; 70:342–6.

8. Kim NH, Kim HY, Seo JA, Kim NH, Choi KM, Baik SH, Choi DS, Kim SG. A pooled analysis of 29 patients with fulminant type 1 diabetes in Korea: a comparison with a nationwide survey in Japan. Diabetes Res Clin Pract. 2009; 86:e43–5.

9. Yu HK, Nam M, Shim WS, Chung HJ, Kim EJ, Hong SB, Kim YS. A case of fulminant type 1 diabetes associated with pregnancy. J Korean Diabetes Assoc. 2007; 31:180–3.

10. Kim HS, Lee TY, Kim EY, Choi JH, Kim SY, Hwang YC, Kang JH, Ahn KJ, Chung HY, Jeong IK. Fulminant type 1 diabetes in a pregnant woman as an initial manifestation of the insulin autoimmune syndrome. Diabet Med. 2012; 29:1335–8.

11. Shimizu I, Makino H, Imagawa A, Iwahashi H, Uchigata Y, Kanatsuka A, Kawasaki E, Kobayashi T, Shimada A, Maruyama T, Hanafusa T. Clinical and immunogenetic characteristics of fulminant type 1 diabetes associated with pregnancy. J Clin Endocrinol Metab. 2006; 91:471–6.

12. Shimizu I, Makino H, Osawa H, Kounoue E, Imagawa A, Hanafusa T, Kawasaki E, Fujii Y. Association of fulminant type 1 diabetes with pregnancy. Diabetes Res Clin Pract. 2003; 62:33–8.

13. Mellor AL, Munn DH. Immunology at the maternal-fetal interface: lessons for T cell tolerance and suppression. Annu Rev Immunol. 2000; 18:367–91.

14. Imagawa A, Hanafusa T, Makino H, Miyagawa JI, Juto P. High titres of IgA antibodies to enterovirus in fulminant type-1 diabetes. Diabetologia. 2005; 48:290–3.

15. Sekine N, Motokura T, Oki T, Umeda Y, Sasaki N, Hayashi M, Sato H, Fujita T, Kaneko T, Asano Y, Kikuchi K. Rapid loss of insulin secretion in a patient with fulminant type 1 diabetes mellitus and carbamazepine hypersensitivity syndrome. JAMA. 2001; 285:1153–4.

16. Sano H, Terasaki J, Tsutsumi C, Imagawa A, Hanafusa T. A case of fulminant type 1 diabetes mellitus after influenza B infection. Diabetes Res Clin Pract. 2008; 79:e8–9.

17. Akatsuka H, Yano Y, Gabazza EC, Morser J, Sasaki R, Suzuki T, Fujiwara R, Katsuki A, Takei Y, Sumida Y. A case of fulminant type 1 diabetes with coxsackie B4 virus infection diagnosed by elevated serum levels of neutralizing antibody. Diabetes Res Clin Pract. 2009; 84:e50–2.

18. Catalano PM, Tyzbir ED, Roman NM, Amini SB, Sims EA. Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol. 1991; 165:1667–72.

19. Zhang L, Sugiyama T, Murabayashi N, Umekawa T, Ma N, Kamimoto Y, Ogawa Y, Sagawa N. The inflammatory changes of adipose tissue in late pregnant mice. J Mol Endocrinol. 2011; 47:157–65.

20. Kamalakannan D, Baskar V, Barton DM, Abdu TA. Diabetic ketoacidosis in pregnancy. Postgrad Med J. 2003; 79:454–7.

TOOLS

Similar articles